PureHealth Holding PJSC reported a net profit of USD 137.6 million and EBITDA of USD 308.5 million for Q1 2025, with revenue reaching USD 1.8 billion—an 8% year-on-year increase. The results reflect strong performance across all business lines, especially in the hospital and insurance segments, which benefited from higher patient volumes and expanded market reach. The Group processed over 2.5 million patient interactions across the UAE and UK, while its insurance arm recorded USD 507.4 million in revenue, supported by strong renewals and new market entries.

PureHealth’s procurement, diagnostics, and technology divisions also recorded double-digit growth. Rafed, the procurement arm, saw an 11% revenue increase, while diagnostic services rose 14% year-on-year, supported by the integration of Sheikh Shakhbout Medical City. PureCS, the Group’s tech arm, more than doubled its revenue, driven by clinical and operational system deployments. Strategic highlights included a USD 93.4 million dividend announcement, the launch of new insurance products, and advancements in specialised healthcare and digital platforms.

Looking forward, PureHealth aims to strengthen its global footprint and accelerate its technology-led transformation. With early repayment of USD 502.3 million in debt and a focus on clinical innovation, international acquisitions, and expanded service capabilities, the Group is well-positioned to scale operations and deliver long-term value. The upcoming integration of Hellenic Healthcare Group in Europe signals continued international expansion and reinforces PureHealth’s ambition to build a leading global healthcare platform.

MedTech Spectrum's Summary        

Strong Financial Growth: PureHealth reported an 8% year-on-year increase in revenue to USD 1.8 billion, with EBITDA rising 5% to USD 308.5 million and net profit increasing 3% to USD 137.6 million.

Segment-Wide Operational Gains: All business segments showed solid performance—most notably the hospital segment (USD 1.4 billion revenue), insurance (up 19% YoY), diagnostics (up 14% YoY), and technology services (up 132% YoY).

Strategic Expansion and Innovation: The Group advanced regional and international operations, including new clinics, expanded mental health services, surgical robot deployment in the UK, and a global partnership with AXA—while preparing to integrate Hellenic Healthcare Group in Europe.